Marvin L. White - Jul 17, 2024 Form 4 Insider Report for Aptevo Therapeutics Inc. (APVO)

Role
President and CEO, Director
Signature
/s/ SoYoung Kwon, Attorney-In-Fact
Stock symbol
APVO
Transactions as of
Jul 17, 2024
Transactions value $
$0
Form type
4
Date filed
7/19/2024, 04:34 PM
Previous filing
May 28, 2024
Next filing
Nov 13, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APVO Restricted Stock Unit Award $0 +22.3K $0.00 22.3K Jul 17, 2024 Common Stock 22.3K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
F2 The RSUs vest in three approximately equal annual installments beginning on June 17, 2025.